Iranian Journal of Immunology

Comparison of the Adjuvanticity of Aluminum Salts and Their Combination in Hepatitis B Recombinant Protein Vaccine Assessed in Mice

Document Type : Original Article

Authors

Arash Mahboubi 1
Mohammad Reza Fazeli 2
Rasoul Dinavand 1, 3
Nasrin Samadi 2
Mohammad Sharifzadeh 4
Houshmand Ilka 5
Saeed Azadi 6
Hassan Kalkouei 6
Rasoul Hajikhanmirzaei 6
Mahboubeh Valadkhani 7

1 Department of Pharmaceutics

2 Department of Drug and Food Control

3 Medical Nanotechnology Research Centre, Tehran University of Medical Sciences

4 Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceuticals Quality Assurance Research Center, Medical Sciences/University of Tehran

5 Zist Daru Danesh Ltd

6 Biotechnology Department of Darou Pakhsh Pharmaceutical Mfg. Co.

7 Department of Biological Products, Ministry of Health, Tehran, Iran

https://doi.org/10.22034/iji.2008.17162
Abstract
Background: Several adjuvants have been evaluated for vaccine formulations but alu-minum salts will continue to be used for many years due to their safety, low cost and adjuvanticity with different antigens. Two commonly used aluminum adjuvants, alumi-num hydroxide and aluminum phosphate have different adjuvanticity properties. Com-mercial recombinant protein hepatitis B vaccines containing aluminum hydroxide is fac-ing low induction of immunity in some sections of the vaccinated population. Objec-tive: In this study, to follow the current global efforts in finding more potent hepatitis B vaccine formulations, adjuvanticity of aluminum phosphate, aluminum hydroxide and their combinations has been evaluated.
Methods: The formulated vaccines were admin-istered intra-peritoneally (i.p.) to BALB/c mice and the titer of antibody was determined after 28 days using ELISA technique. The geometric mean of antibody titer (GMT, mIU/ml), seroconversion and seroprotection rates, ED50 (ng) and relative potency (μg/dose) of different formulations were determined.
Results: GMT of antibody titer, seroconversion and seroprotection rates showed significantly higher adjuvanticity for aluminum phosphate than other formulations. The ED50 of aluminum phosphate was approximately two fold less than other formulations.
Conclusion: Aluminum phosphate showed more adjuvanticity than aluminum hydroxide and their combinations in hepati-tis B protein vaccine. The use of aluminum phosphate as adjuvant leads to higher im-munity which may result in more protective response in vaccinated groups.

Keywords

Hepatitis B vaccine
Aluminum
BALB/c Mice
Iranian Journal of Immunology
Volume 5, Issue 3
Summer 2008
Pages 163-170

Home

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us